In patients with longstanding type 1 diabetes, blunting of the glucagon response comes along with the disappearing endogenous insulin production (Cryer, 2008), rendering the patients increasingly dependent upon epinephrine as protection against hypoglycemia. Here, INS is linked to type 1 diabetes mellitus.